PALOMA-2 Final OS Analysis: Addition of Palbociclib to Frontline Letrozole in Postmenopausal ER+/HER2- Advanced Breast Cancer

Commentary from Dr Heather McArthur on latest developments in managing early-stage breast cancer (EBC), from Clinical Care Options (CCO)

Heather McArthur, MD, MPH
Program Director Released: August 4, 2022

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered malignancies.

Alexander Drilon, MD
Program Director Thomas Stinchcombe, MD
Program Director Released: August 4, 2022

Downloadable slideset from a live webinar presented by Jamie Carroll, MSN on managing adverse events and promoting adherence to CDK4/6 and PI3K inhibitors, from Clinical Care Options (CCO)

Robert T. Carroll, PhD(c), RN, ACRN Released: July 26, 2022

Downloadable slideset from a live webinar presented by Sarah Hurvitz, MD, on selecting and sequencing targeted therapy for HR+/HER2- breast cancer, from Clinical Care Options (CCO)

Sara Hurvitz, MD, FACP Released: July 26, 2022